ToliTOLI Corporation7971東証スタンダード化学FY ending Mar 2026, consolidated, J-GAAP
Out of every ¥100 of sales, about ¥5 is left as operating profit. Revenue changed +6.3% from the prior year, operating profit +16.5%.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2022 | 0.8% | 1.11× | 0.9% | 2.22× | 2.0% |
| 2023 | 2.7% | 1.16× | 3.1% | 2.22× | 6.9% |
| 2024 | 3.6% | 1.17× | 4.2% | 2.23× | 9.4% |
| 2025 | 3.3% | 1.14× | 3.8% | 2.22× | 8.4% |
| 2026 | 4.0% | 1.16× | 4.6% | 2.23× | 10.3% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
Track R&D investment and how long operating capital remains tied up before sales turn into cash.
R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 88,513 | 95,230 | 102,470 | 105,709 | 112,337 |
| Cost of revenue | 64,388 | 68,052 | 72,554 | 75,050 | 78,727 |
| Gross profit | 24,124 | 27,177 | 29,915 | 30,659 | 33,610 |
| SG&A | 23,246 | 23,646 | 24,937 | 26,282 | 28,510 |
| Operating income | 878 | 3,531 | 4,978 | 4,376 | 5,100 |
| Pretax income | 1,129 | 3,800 | 5,289 | 5,060 | 6,363 |
| Income tax | 397 | 1,226 | 1,549 | 1,494 | 1,848 |
| Net income attributable to owners | 720 | 2,562 | 3,689 | 3,507 | 4,459 |
| Operating margin | 1.0% | 3.7% | 4.9% | 4.1% | 4.5% |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
Each bar totals 100% of assets; other is the residual.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥10.2B | ¥9.59B | ¥9.46B | ¥8.03B | ¥10B |
| Total assets | ¥80B | ¥84.8B | ¥90.8B | ¥94.1B | ¥99.6B |
| Net assets | ¥38.3B | ¥40.9B | ¥45.8B | ¥48.4B | ¥52.2B |
| Share capital | ¥6.86B | ¥6.86B | ¥6.86B | ¥6.86B | ¥6.86B |
| Trade receivables | ¥18.9B | ¥20.3B | ¥20.1B | ¥19.3B | ¥16.6B |
| Property, plant and equipment | ¥22.1B | ¥23B | ¥24.6B | ¥26.9B | ¥28.7B |
| Intangible assets excluding goodwill | ¥989M | ¥811M | ¥675M | ¥638M | ¥706M |
| Investment securities | ¥4.71B | ¥5.2B | ¥7.63B | ¥8.28B | ¥10.3B |
| Current assets | ¥46.8B | ¥50.7B | ¥52.9B | ¥52.7B | ¥54.1B |
| Current liabilities | ¥29.4B | ¥31.7B | ¥34.1B | ¥32.8B | ¥34.2B |
| Trade payables | ¥17.6B | ¥18.2B | ¥17.7B | ¥15.2B | ¥14.4B |
| Short-term borrowings | ¥920M | ¥1.02B | ¥2.22B | ¥4.05B | ¥4.43B |
| Long-term borrowings | ¥5.78B | ¥5.68B | ¥4.48B | ¥5.73B | ¥5.75B |
| Total liabilities | ¥41.7B | ¥43.9B | ¥45.1B | ¥45.7B | ¥47.5B |
| Non-controlling interests | ¥271M | ¥281M | ¥326M | ¥331M | ¥379M |
| Equity attributable to owners of parent | ¥36B | ¥38.1B | ¥40.7B | ¥42.5B | ¥44.2B |
| Retained earnings | ¥24.2B | ¥26.3B | ¥29.2B | ¥31.5B | ¥34.4B |
| Treasury stock | -¥1.47B | -¥1.5B | -¥227M | -¥687M | -¥1.88B |
EDINET (FSA Japan)
有価証券報告書－第162期(2025/04/01－2026/03/31)
EDINET (FSA Japan)
有価証券報告書－第161期(2024/04/01－2025/03/31)
EDINET (FSA Japan)
有価証券報告書－第160期(2023/04/01－2024/03/31)
EDINET (FSA Japan)
有価証券報告書－第159期(2022/04/01－2023/03/31)
EDINET (FSA Japan)
有価証券報告書－第158期(令和3年4月1日－令和4年3月31日)
EDINET (FSA Japan)
有価証券報告書－第157期(令和2年4月1日－令和3年3月31日)
Extracted from XBRL: 54 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.